Sternocleidomastoid Thickness in Sarcopenia

Launched by NAMIK KEMAL UNIVERSITY · Jun 23, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating the thickness of a neck muscle called the sternocleidomastoid in patients with sarcopenia, which is a condition characterized by muscle loss often seen in those in intensive care. Researchers want to see how measuring this muscle thickness with a simple ultrasound can help understand and prevent sarcopenia in these patients. While other muscles have been studied before, the sternocleidomastoid muscle hasn’t been explored in this context, and the study aims to fill that gap.

To participate in the trial, you need to be at least 18 years old and expected to stay in the intensive care unit (ICU) for a week or more. Unfortunately, patients under 18, those with specific injuries, or certain medical conditions that would prevent imaging can't participate. If you join the study, you can expect to have your muscle thickness measured using ultrasound, which is a safe and non-invasive procedure. This research could help improve nutritional support and treatments for patients in the ICU, ultimately enhancing recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are expected to be followed up in the intensive care unit for at least 1 week
• • Patients over 18 years old
• Exclusion Criteria:
• • Patients under 18 years of age
• • Head-neck, femur trauma patients
• • Those with a diagnosis of primary neuromuscular disease
• • Those who have a condition that prevents imaging in the body parts where ultrasonography is planned